MarketInOut Stock Screener Log In | Sign Up

Caplin Point Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Caplin Point Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization178,704 mln
Float20.31 mln

EPS

86.87
Exceptional

P / E

26.90
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.99
Caution advised

Relative Strength

82 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

Business Description

Founded in 1990 and based in Chennai, India, Caplin Point Laboratories develops, manufactures, and sells a wide range of generic and branded medicines for both domestic and international markets. The company's product portfolio spans nearly every major dosage form, including tablets, capsules, injectable solutions, eye drops, creams, inhalers, and intravenous infusions, among many others.

Key Fundamentals

EPS86.87
P/E26.90
ROE20.80
RPS301
ROIC24.37
ROA18.55
Interest Cover816
EBITDA, mln9,225
EV / EBITDA17.80
EV / EBIT19.44
Revenue, mln22,873
EV / Revenue7.18

Quote Details

Last 2,336.40
Change -34.2 (-1.44%)
Open 2,391.25
Volume 5,703
Turnover 13,324,489
Average Volume 8,582.33

Financial Ratios

Pre-Tax Profit Margin37
Leverage Ratio1.13
Current Ratio6.70
Price / Book5.10
Price / Tangible Book5.18
Price / Cash Flow70.64
Price / Free Cash Flow55.17
Debt / Equity0.00
Price / Sales7.85
PEG Ratio1.34

Financial Strength

Altman Z-Score27.91
Piotroski F-Score 6 / 9
Beneish M-Score-1.99
Price to Intrinsic Value3.09
Price to Lynch Fair Value1.35
Price to Graham Number2.54
Shiller PE Ratio45.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.05% 80 / 100   
1 Month -14.73% 19 / 100   
2 Months -5.45% 56 / 100   
6 Months 35.86% 89 / 100   
1 Year 15.41% 82 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog